Armada Nutrition
Letter data
- Company
- Armada Nutrition
- Recipient
- Armada Nutrition | United States
- Issue date
- 2018-03-13
- Posted date
- Not available
- FDA office
- United States
- Subject
- Not available
- Product
- Not available
- CMS ID
- Not available
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Armada Nutrition
March 13, 2018
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Recipient:
Armada Nutrition
United States
Issuing Office:
United States
Cincinnati District Office
6751 Steger Drive
Cincinnati, OH 45237
Telephone: (513) 679-2700
FAX: (513) 679-2772
VIA Email
March 13, 2018
Mr. Brent A. Laffey, President
Armada Nutrition, LLC
4637 Port Royal Rd.
Spring Hill, TN 37174-2834
The Food and Drug Administration (FDA) has completed an evaluation of your firm 's corrective actions in response to our Warning Letter 523876 dated August 1, 2017. Based on our evaluation, it appears that you have addressed the violations and/or deviations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The FDA expects you and your firm to maintain compliance with current good manufacturing practices and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations and/or deviations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Stephen J. Rabe
Compliance Officer
Content current as of:
03/19/2018